Both in Pharmaceuticals
Amarin vs Structure Therapeutics
Over the past year AMRN returned −27.2% and GPCR returned −39.9%; their daily moves had a correlation of -0.06.
AMRN −27.2% GPCR −39.9%Growth of $1, one year, split-adjusted
| Metric | AMRN | GPCR |
|---|---|---|
| Price | $11.71 | $20.95 |
| Market cap | $492.3M | $1.49B |
| Today | −0.34% | −3.59% |
| 1 month | +1.1% | −6.1% |
| 6 months | −22.0% | −45.0% |
| Year to date | −16.1% | −69.9% |
| 1 year | −26.1% | −38.2% |
| Revenue growth (YoY) | −20.4% | — |
| Gross margin | 40.9% | — |
| Net margin | 0.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 2.8× | — |
| Net cash | $323.4M | $1.34B |
| Dividend yield | — | — |
| Volatility (60d) | 31.1% | 61.2% |
| Short % of float | — | — |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).